サマリー

放射性医薬品の世界市場 2023-2027
放射性医薬品市場は2022-2027年に4612.62百万米ドルの成長が予測され、予測期間中のCAGRは10.22%で加速すると予測されています。この調査レポートは、放射性医薬品市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。神経疾患の罹患率の上昇、がん患者の増加、腫瘍学市場への投資の増加、放射性医薬品の副作用の最小化などが市場を牽引しています。
Technavioの放射性医薬品市場は以下のように区分されています：
ソース別
- サイクロトロン
- 原子炉
エンドユーザー別
- 診断薬
- 治療薬
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、サイクロトロンベースの放射性医薬品の生産が、今後数年間の放射性医薬品市場の成長を促進する主要な理由の1つであると特定しています。また、新しい放射性医薬品の発見と開発、新興国における医療インフラの改善は、市場の大きな需要につながるでしょう。
本レポートでは、放射性医薬品市場について以下の分野をカバーしています：
- 放射性医薬品市場のサイジング
- 放射性医薬品市場予測
- 放射性医薬品市場の産業分析
強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って本レポートでは、Bayer AG、Bracco Spa、Cardinal Health Inc.、Curium Pharma、Eckert and Ziegler AG、General Electric Co、IBA Radiopharma Solutions、Jubilant Pharma Ltd.、Lantheus Holdings Inc.、Mallinckrodt Plc、NorthStar Medical Radioisotopes LLC、Novartis AG、NTP Radioisotopes SOC Ltd.、PharmaLogic Holdings Corp.、Positron Corp.、Radiomedix Inc.、Siemens AG、Sinotau Pharmaceuticals、Telix Pharmaceuticals Ltd.、Sotera Health Co.などである。また、放射性医薬品市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/radiopharmaceuticals-market-size-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Source
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global radiopharmaceuticals market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global radiopharmaceuticals market 2017 - 2021 ($ million)
o 4.2 Source Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Source Segment 2017 - 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Source
o 6.1 Market segments
o Exhibit 30: Chart on Source - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Source - Market share 2022-2027 (%)
o 6.2 Comparison by Source
o Exhibit 32: Chart on Comparison by Source
o Exhibit 33: Data Table on Comparison by Source
o 6.3 Cyclotrons - Market size and forecast 2022-2027
o Exhibit 34: Chart on Cyclotrons - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Cyclotrons - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Cyclotrons - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Cyclotrons - Year-over-year growth 2022-2027 (%)
o 6.4 Nuclear reactors - Market size and forecast 2022-2027
o Exhibit 38: Chart on Nuclear reactors - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Nuclear reactors - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Nuclear reactors - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Nuclear reactors - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Source
o Exhibit 42: Market opportunity by Source ($ million)
o Exhibit 43: Data Table on Market opportunity by Source ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 46: Chart on Comparison by End-user
o Exhibit 47: Data Table on Comparison by End-user
o 7.3 Diagnostics - Market size and forecast 2022-2027
o Exhibit 48: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)
o 7.4 Therapeutics - Market size and forecast 2022-2027
o Exhibit 52: Chart on Therapeutics - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Therapeutics - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Therapeutics - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Therapeutics - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by End-user
o Exhibit 56: Market opportunity by End-user ($ million)
o Exhibit 57: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Bayer AG
o Exhibit 107: Bayer AG - Overview
o Exhibit 108: Bayer AG - Business segments
o Exhibit 109: Bayer AG - Key news
o Exhibit 110: Bayer AG - Key offerings
o Exhibit 111: Bayer AG - Segment focus
o 12.4 Bracco Spa
o Exhibit 112: Bracco Spa - Overview
o Exhibit 113: Bracco Spa - Product / Service
o Exhibit 114: Bracco Spa - Key offerings
o 12.5 Cardinal Health Inc.
o Exhibit 115: Cardinal Health Inc. - Overview
o Exhibit 116: Cardinal Health Inc. - Business segments
o Exhibit 117: Cardinal Health Inc. - Key news
o Exhibit 118: Cardinal Health Inc. - Key offerings
o Exhibit 119: Cardinal Health Inc. - Segment focus
o 12.6 Curium Pharma
o Exhibit 120: Curium Pharma - Overview
o Exhibit 121: Curium Pharma - Product / Service
o Exhibit 122: Curium Pharma - Key offerings
o 12.7 Eckert and Ziegler AG
o Exhibit 123: Eckert and Ziegler AG - Overview
o Exhibit 124: Eckert and Ziegler AG - Business segments
o Exhibit 125: Eckert and Ziegler AG - Key news
o Exhibit 126: Eckert and Ziegler AG - Key offerings
o Exhibit 127: Eckert and Ziegler AG - Segment focus
o 12.8 General Electric Co.
o Exhibit 128: General Electric Co. - Overview
o Exhibit 129: General Electric Co. - Business segments
o Exhibit 130: General Electric Co. - Key news
o Exhibit 131: General Electric Co. - Key offerings
o Exhibit 132: General Electric Co. - Segment focus
o 12.9 IBA Radiopharma Solutions
o Exhibit 133: IBA Radiopharma Solutions - Overview
o Exhibit 134: IBA Radiopharma Solutions - Business segments
o Exhibit 135: IBA Radiopharma Solutions - Key offerings
o Exhibit 136: IBA Radiopharma Solutions - Segment focus
o 12.10 Jubilant Pharma Ltd.
o Exhibit 137: Jubilant Pharma Ltd. - Overview
o Exhibit 138: Jubilant Pharma Ltd. - Product / Service
o Exhibit 139: Jubilant Pharma Ltd. - Key offerings
o 12.11 Lantheus Holdings Inc.
o Exhibit 140: Lantheus Holdings Inc. - Overview
o Exhibit 141: Lantheus Holdings Inc. - Business segments
o Exhibit 142: Lantheus Holdings Inc. - Key offerings
o Exhibit 143: Lantheus Holdings Inc. - Segment focus
o 12.12 NorthStar Medical Radioisotopes LLC
o Exhibit 144: NorthStar Medical Radioisotopes LLC - Overview
o Exhibit 145: NorthStar Medical Radioisotopes LLC - Product / Service
o Exhibit 146: NorthStar Medical Radioisotopes LLC - Key offerings
o 12.13 Novartis AG
o Exhibit 147: Novartis AG - Overview
o Exhibit 148: Novartis AG - Business segments
o Exhibit 149: Novartis AG - Key offerings
o Exhibit 150: Novartis AG - Segment focus
o 12.14 NTP Radioisotopes SOC Ltd.
o Exhibit 151: NTP Radioisotopes SOC Ltd. - Overview
o Exhibit 152: NTP Radioisotopes SOC Ltd. - Product / Service
o Exhibit 153: NTP Radioisotopes SOC Ltd. - Key offerings
o 12.15 PharmaLogic Holdings Corp.
o Exhibit 154: PharmaLogic Holdings Corp. - Overview
o Exhibit 155: PharmaLogic Holdings Corp. - Product / Service
o Exhibit 156: PharmaLogic Holdings Corp. - Key offerings
o 12.16 Siemens AG
o Exhibit 157: Siemens AG - Overview
o Exhibit 158: Siemens AG - Business segments
o Exhibit 159: Siemens AG - Key news
o Exhibit 160: Siemens AG - Key offerings
o Exhibit 161: Siemens AG - Segment focus
o 12.17 Sotera Health Co.
o Exhibit 162: Sotera Health Co. - Overview
o Exhibit 163: Sotera Health Co. - Business segments
o Exhibit 164: Sotera Health Co. - Key offerings
o Exhibit 165: Sotera Health Co. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 166: Inclusions checklist
o Exhibit 167: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 168: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 169: Research methodology
o Exhibit 170: Validation techniques employed for market sizing
o Exhibit 171: Information sources
o 13.5 List of abbreviations
o Exhibit 172: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Source
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global radiopharmaceuticals market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Source Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Source - Market share 2022-2027 (%)
Exhibits31: Data Table on Source - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Source
Exhibits33: Data Table on Comparison by Source
Exhibits34: Chart on Cyclotrons - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Cyclotrons - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Cyclotrons - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Cyclotrons - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Nuclear reactors - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Nuclear reactors - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Nuclear reactors - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Nuclear reactors - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Source ($ million)
Exhibits43: Data Table on Market opportunity by Source ($ million)
Exhibits44: Chart on End-user - Market share 2022-2027 (%)
Exhibits45: Data Table on End-user - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by End-user
Exhibits47: Data Table on Comparison by End-user
Exhibits48: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Therapeutics - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Therapeutics - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by End-user ($ million)
Exhibits57: Data Table on Market opportunity by End-user ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Bayer AG - Overview
Exhibits108: Bayer AG - Business segments
Exhibits109: Bayer AG - Key news
Exhibits110: Bayer AG - Key offerings
Exhibits111: Bayer AG - Segment focus
Exhibits112: Bracco Spa - Overview
Exhibits113: Bracco Spa - Product / Service
Exhibits114: Bracco Spa - Key offerings
Exhibits115: Cardinal Health Inc. - Overview
Exhibits116: Cardinal Health Inc. - Business segments
Exhibits117: Cardinal Health Inc. - Key news
Exhibits118: Cardinal Health Inc. - Key offerings
Exhibits119: Cardinal Health Inc. - Segment focus
Exhibits120: Curium Pharma - Overview
Exhibits121: Curium Pharma - Product / Service
Exhibits122: Curium Pharma - Key offerings
Exhibits123: Eckert and Ziegler AG - Overview
Exhibits124: Eckert and Ziegler AG - Business segments
Exhibits125: Eckert and Ziegler AG - Key news
Exhibits126: Eckert and Ziegler AG - Key offerings
Exhibits127: Eckert and Ziegler AG - Segment focus
Exhibits128: General Electric Co. - Overview
Exhibits129: General Electric Co. - Business segments
Exhibits130: General Electric Co. - Key news
Exhibits131: General Electric Co. - Key offerings
Exhibits132: General Electric Co. - Segment focus
Exhibits133: IBA Radiopharma Solutions - Overview
Exhibits134: IBA Radiopharma Solutions - Business segments
Exhibits135: IBA Radiopharma Solutions - Key offerings
Exhibits136: IBA Radiopharma Solutions - Segment focus
Exhibits137: Jubilant Pharma Ltd. - Overview
Exhibits138: Jubilant Pharma Ltd. - Product / Service
Exhibits139: Jubilant Pharma Ltd. - Key offerings
Exhibits140: Lantheus Holdings Inc. - Overview
Exhibits141: Lantheus Holdings Inc. - Business segments
Exhibits142: Lantheus Holdings Inc. - Key offerings
Exhibits143: Lantheus Holdings Inc. - Segment focus
Exhibits144: NorthStar Medical Radioisotopes LLC - Overview
Exhibits145: NorthStar Medical Radioisotopes LLC - Product / Service
Exhibits146: NorthStar Medical Radioisotopes LLC - Key offerings
Exhibits147: Novartis AG - Overview
Exhibits148: Novartis AG - Business segments
Exhibits149: Novartis AG - Key offerings
Exhibits150: Novartis AG - Segment focus
Exhibits151: NTP Radioisotopes SOC Ltd. - Overview
Exhibits152: NTP Radioisotopes SOC Ltd. - Product / Service
Exhibits153: NTP Radioisotopes SOC Ltd. - Key offerings
Exhibits154: PharmaLogic Holdings Corp. - Overview
Exhibits155: PharmaLogic Holdings Corp. - Product / Service
Exhibits156: PharmaLogic Holdings Corp. - Key offerings
Exhibits157: Siemens AG - Overview
Exhibits158: Siemens AG - Business segments
Exhibits159: Siemens AG - Key news
Exhibits160: Siemens AG - Key offerings
Exhibits161: Siemens AG - Segment focus
Exhibits162: Sotera Health Co. - Overview
Exhibits163: Sotera Health Co. - Business segments
Exhibits164: Sotera Health Co. - Key offerings
Exhibits165: Sotera Health Co. - Segment focus
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Validation techniques employed for market sizing
Exhibits171: Information sources
Exhibits172: List of abbreviations